Flu drugs: Govts urged to bypass patent laws

As China reported its third outbreak of bird flu in a week, public health groups have urged officials to bypass patent laws and mass-produce generic versions of potentially lifesaving anti-viral drugs.

As China reported its third outbreak of bird flu in a week, public health groups have urged officials to bypass patent laws and mass-produce generic versions of potentially lifesaving anti-viral drugs.

Under World Trade Organisation rules, countries facing a public health emergency can issue so-called compulsory licenses to legally manufacture and export generic versions of patented drugs under strict conditions.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited